Freedom Acquisition I 

Freedom Acquisition I Corp. operates as a blank check company formed for the purpose of entering into a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Tidjane Thiam, Adam Gishen and Abhishek Bhatia on December 23, 2020 and is headquartered in New York, NY.

Facet Biotech Corporation, a biotechnology company, engages in the identification and development of oncology drugs. Facet was formed through a spin-off of the biotechnology segment of PDL BioPharma, Inc., which was completed on December 18, 2008. It was subsequently acquired by [Abbott Labs](/organization/abbott-labs). The company is headquartered in Redwood City, California.  Its products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company is also developing Elotuzumab, a monoclonal antibody in Phase I/II clinical studies, which binds to a cell surface glycoprotein that is expressed on myeloma cells and normal human cells; PDL192, a monoclonal antibody in Phase I clinical study, which binds to the tumor necrosis factor-like weak inducer of apoptosis receptor; PDL241, a monoclonal antibody in the preclinical stage for immunologic diseases; and TRU-016, a small modular immunopharmaceutical protein therapeutic in Phase I clinical studies for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin's lymphoma, as well as autoimmune and inflammatory disease indications. It has collaboration agreements with Biogen Idec Inc.; Bristol-Myers Squibb Company; and Trubion Pharmaceuticals, Inc. Facet Biotech Corporation also has license agreements with Abbott Laboratories, Inc.; Actinium Pharmaceuticals, Inc.; Genentech, Inc.; Ophthotech Corporation; Progenics Pharmaceuticals, Inc.; and Seattle Genetics, Inc.

Complete Solaria Inc

Complete Solaria is a differentiated solar company, with unique technology and end-to-end solar solutions, which includes financing, project fulfilment and customer service. Complete Solaria's digital platform together with premium solar products provide a one-stop service for customers.

Complete Solaria, a Leading Solar Technology, Services, and Installation Company, Completes Business Combination with Freedom Acquisition I Corp. and Will Commence Trading on Nasdaq Under Ticker Symbol “CSLR”

FREMONT, Calif.--(BUSINESS WIRE)--The Boards of Directors of Complete Solaria, Inc. (“Complete Solaria” or the “Company”) and Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), today announced approval of the proposed business combination. In addition, Complete Solaria and Freedom announced a $10 million commitment from T.J. Rodgers in connection with the proposed business combination. The proposed business combination would bring Complete Solaria to market, as a full system operator with a.

Boards of Complete Solaria and Freedom Acquisition I Corp. Approve Business Combination; Additional $10 Million Commitment Made by T.J. Rodgers

FREMONT, Calif.--(BUSINESS WIRE)--Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, today announced that its shareholders voted to approve the previously announced business combination with Complete Solaria, Inc. (“Complete Solaria”), at the extraordinary general meeting of Freedom's shareholders held on July 11, 2023 (the “Special Meeting”). Votes representing over 76.9% of the issued and outstanding ordinary shares of Freedom were cas.

Freedom Acquisition I Corp. Shareholders Approve Previously Announced Business Combination with Complete Solaria, Inc.

FREMONT, Calif.--(BUSINESS WIRE)--Complete Solaria, Inc. (“Complete Solaria”), a leading solar technology, services, and installation company, Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, CS Solis LLC, a Delaware limited liability company, and CRSEF Solis Holdings, L.L.C., a Delaware limited liability company, today announced they have entered into a consent agreement related to the proposed business combination between Complete So.

Complete Solaria, Freedom Acquisition I Corp., CS Solis LLC and CRSEF Solis Holdings, L.L.C. Enter into Consent to Business Combination Agreement in Support of Proposed Business Combination

FREMONT, Calif.--(BUSINESS WIRE)--Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, today announced that, upon the consummation of its previously announced proposed business combination (the “Business Combination”) with Complete Solaria, Inc. (“Complete Solaria”), a leading solar technology, services, and installation company, the combined entity is expected to list its shares of common stock and warrants on the Nasdaq Stock Market (“Na.

Freedom Acquisition I Corp. Announces Planned Listing by Combined Entity on Nasdaq Upon Consummation of Proposed Business Combination with Complete Solaria, Inc.

FREMONT, Calif.--(BUSINESS WIRE)--Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, today announced that Freedom's registration statement on Form S-4 (the “Registration Statement”), relating to the previously announced proposed business combination between Freedom and Complete Solaria, Inc. (“Complete Solaria”), a leading solar technology, services, and installation company, has been declared effective by the U.S. Securities and Exchang.

Freedom Acquisition I Corp. Announces Effectiveness of Registration Statement and July 11, 2023 Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination with Complete Solaria, Inc.

FREMONT, Calif.--(BUSINESS WIRE)--Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a leading solar technology, services, and installation company, today announced it will be hosting a one-hour virtual update on May 23, 2023 at 11:00 AM ET, to review its Q1 results, pending business combination, and market backdrop for residential solar. The formal presentation will be followed by a live question and answer session. Registration is required for this virtual event. To register click.

Complete Solaria to Hold First Quarter & Business Update on May 23, 2023

SAN RAMON, Calif.--(BUSINESS WIRE)--Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly-traded special purpose acquisition company, and Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a leading solar technology, services, and installation company, announced that Freedom filed a registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on February 10, 2023.

Freedom Acquisition I Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Complete Solaria

SAN RAMON, Calif.--( BUSINESS WIRE )--Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a leading solar technology, services, and installation company, today announced that Brian Wuebbels has been named Chief Financial Officer, effective February 1, 2023. Wuebbels brings more than 20 years of financial and executive experience, having served as CFO and in senior leadership positions for public and private solar and industrial companies throughout his career, including companies such NIDEC, GCL Solar Materials, SunEdison, Honeywell, and General Electric.

Complete Solaria Appoints Industry Veteran Brian Wuebbels as Chief Financial Officer

SAN RAMON, Calif.--( BUSINESS WIRE )--Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a leading solar technology, services, and installation company, and Freedom Acquisition I Corp. (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, today announced that Complete Solaria will be hosting a Virtual Investor & Analyst Day on Monday, February 13, 2023 at 11:00 am EST.

Complete Solaria to Host Virtual Investor & Analyst Day on February 13, 2023

SAN RAMON, Calif.--( BUSINESS WIRE )--Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a leading solar technology, services, and installation company, and Freedom Acquisition I Corp. (NYSE: FACT), a publicly traded special purpose acquisition company, (“Freedom”) today announced a number of positive financial developments in connection with their proposed business combination (“Business Combination”).

Complete Solaria and Freedom Acquisition I Corp. Achieve Important Milestones Towards Completion of Business Combination

Complete Solar Merges with Solaria, Forming Complete Solaria, an Industry Leading Solar Company

Complete Solaria and Freedom Acquisition Engage Cohen & Company and Marathon Capital as Advisors for Business Combination

Special purpose acquisition company (SPAC) Freedom Acquisition I Corp (NYSE: FACT ) generated some headlines on Monday when it announced a reverse merger agreement with solar energy specialist Complete Solaria. Unlike some other speculative SPACs, several high-profile accredited and institutional investors, including Carlyle Group (NASDAQ: CG ) support FACT stock.

FACT Stock: What to Know as Complete Solaria Goes Public

SAN RAMON, Calif.--(BUSINESS WIRE)--Complete Solaria, Inc. (“Complete Solaria” or the “Company”), a solar technology, services and financing company, and Freedom Acquisition I Corp. (NYSE: FACT), a publicly traded special purpose acquisition company, today announced a definitive agreement for a business combination that will result in Complete Solaria becoming a publicly listed company. Upon the closing of the business combination, the Company is expected to remain listed on the New York Stock

Complete Solaria, an Industry-Leading Solar Services, Financing and Products Company, to Publicly List on NYSE through Business Combination with Freedom Acquisition I Corp.

SAN DIEGO & LONDON--(BUSINESS WIRE)--Human Longevity, Inc. (“HLI”), built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, announced today that they have signed a non-binding letter of intent (the “Letter of Intent”) for a proposed business combination that would result in HLI becoming a publicly listed company. Upon the closing of the transaction, the combined company wo

News for Freedom Acquisition I Stock (FACT)